skip to main content

COPD inhaler duplication — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRespiratory TherapeuticsCOPD inhaler duplicationGPhC CRA

A COPD patient presents repeats for tiotropium and umeclidinium. They say both were issued by different clinics. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Clarify therapy because both are long-acting muscarinic antagonists

Using two LAMA inhalers duplicates treatment and may increase antimuscarinic adverse effects. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: BNF; NICE CKS; BTS/NICE/SIGN asthma guideline